| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| 2022 | 2023 | 2024 | Q'25 | |
|---|---|---|---|---|
| Cash | 0.44 | 0.18 | 0.52 | 2.91 |
| Receivables | 0.46 | 0.21 | 0.04 | 0.03 |
| Inventory | 0.58 | 0.57 | 0.52 | 0.50 |
| Other | — | — | — | — |
| 1.74 | 1.35 | 2.02 | 3.82 |
| 2022 | 2023 | 2024 | Q'25 | |
|---|---|---|---|---|
| Payables | 1.02 | 3.21 | 1.98 | 1.70 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 7.25 | 7.58 | 8.20 | 9.72 |
| 10y | 5y | 3y | |
| Sales | — | — | — |
| Cash Flow | — | — | — |
| Earnings | — | — | — |
| Book Value | — | — | — |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 3.64 | 4.28 | 4.32 | — |
—
|
| ’24 | 4.83 | 4.39 | 4.05 | 3.32 |
16.59
|
| ’23 | 4.28 | 4.49 | 4.12 | 3.78 |
16.68
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.37) | (0.90) | (1.28) | — |
—
|
| ’24 | (3.17) | 0.15 | (6.31) | (0.68) |
(10.01)
|
| ’23 | (0.31) | (0.20) | (2.56) | (0.75) |
(3.82)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.39) | (0.91) | (1.33) | — |
—
|
| ’24 | (3.33) | 0.13 | (6.33) | (0.71) |
(10.24)
|
| ’23 | (0.32) | (0.31) | (2.80) | (0.78) |
(4.20)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.43) | (0.50) | (0.41) | — |
—
|
| ’24 | (224.25) | (17.50) | (9.50) | (0.86) |
(2.61)
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | 778.25 | 4.21 | — | — | — |
Low Price
|
| — | — | — | — | — | — | — | — | 10,250.00 | 1,250.00 | — | — | — |
High Price
|
| — | — | — | — | — | — | — | 30 | 156 | 113 | — | — | — |
Employees
|
| — | — | — | — | — | — | — | 0.33 | 0.11 | 0.15 | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | — | — | 9.83 | 16.68 | 16.59 | — | — | — |
Revenue
|
| — | — | — | — | — | — | — | 25.88% | 21.31% | 19.84% | — | — | — |
Gross Margin
|
| — | — | — | — | — | — | — | (4.94) | (14.79) | (14.26) | — | — | — |
EBT
|
| — | — | — | — | — | — | — | (50.25%) | (88.71%) | (85.97%) | — | — | — |
EBT Margin
|
| — | — | — | — | — | — | — | (4.91) | (14.79) | (14.26) | — | — | — |
Net Income
|
| — | — | — | — | — | — | — | 1.49 | 2.41 | 3.96 | — | — | — |
Depreciation
|
| — | — | — | — | — | — | — | 4,683.24 | 3.87 | 2.99 | — | — | — |
Revenue/Sh
|
| — | — | — | — | — | — | — | — | (5,625.00) | (2.61) | — | — | — |
Earnings/Sh
|
| — | — | — | — | — | — | — | (1,265.86) | (0.89) | (1.80) | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | — | — | — | (84.19) | (0.09) | (0.04) | — | — | — |
Capex/Sh
|
| — | — | — | — | — | — | — | (1,350.05) | (0.98) | (1.85) | — | — | — |
Free CF/Sh
|
| — | — | — | — | — | — | — | (2,445.48) | (0.18) | 0.28 | — | — | — |
Book Value/Sh
|
| — | — | — | — | — | — | — | 0.00 | 4.31 | 5.55 | — | — | — |
Shares
|
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| — | — | — | — | — | — | — | 0.00 | 231.96 | 1.60 | — | — | — |
PS Ratio
|
| — | — | — | — | — | — | — | 0.00 | 0.00 | 17.02 | — | — | — |
PB Ratio
|
| — | — | — | — | — | — | — | 0.00 | 232.76 | 2.08 | — | — | — |
EV/Sales
|
| — | — | — | — | — | — | — | (391.91) | (923.14) | (2.96) | — | — | — |
EV/FCF
|
| — | — | — | — | — | — | — | (2.66) | (3.82) | (10.01) | — | — | — |
Op' Cash Flow
|
| — | — | — | — | — | — | — | (0.18) | (0.38) | (0.24) | — | — | — |
Capex
|
| — | — | — | — | — | — | — | (2.84) | (4.20) | (10.24) | — | — | — |
FCF
|
| — | — | — | — | — | — | — | (5.51) | (6.23) | (6.18) | — | — | — |
Working Cap'
|
| — | — | — | — | — | — | — | 17.41 | 13.48 | 8.49 | — | — | — |
Total Debt
|
| — | — | — | — | — | — | — | 16.96 | 13.30 | 7.97 | — | — | — |
Net Debt
|
| — | — | — | — | — | — | — | (5.14) | (0.79) | 1.56 | — | — | — |
Sh' Equity
|
| — | — | — | — | — | — | — | 0.00% | (71.77%) | (69.00%) | — | — | — |
ROA
|
| — | — | — | — | — | — | — | (18.59%) | (35.83%) | (59.21%) | — | — | — |
ROIC
|
| — | — | — | — | — | — | — | 0.00% | 508.60% | (3,744.37%) | — | — | — |
ROE
|
Inspire Veterinary Partners (IVPR) burst onto the scene via a 2024 SPAC merger, riding the post-COVID pet ownership boom with aggressive clinic expansions that drove revenue from $9.8M in 2022 to $16.7M in 2023—yet hit a plateau in 2024 amid scaling pains, eroding margins (down to 19.8%), deepening losses, and heavy share dilution. Despite the stock’s wild volatility and 99%+ valuation wipeout, a bright spot emerges: debt slashed 51% to $8.5M, normalizing multiples like EV/Sales to a compelling 2.1x and boosting equity to positive territory, signaling smart deleveraging amid sector-wide vet staffing crunches.
Looking ahead, IVPR sits at the intersection of explosive U.S. pet spending ($150B in 2024, growing 5-7% annually) and consolidation opportunities, with upside potential from 10-15 new clinics and efficiency rebounds (revenue per employee could hit $180K). While cash burn persists, projected loss narrowing and a 20-30% recovery odds on positive earnings surprises make this high-beta play a speculative gem for turnaround hunters—especially as peers navigate similar M&A waves.
Dive into the full analysis for data-driven projections, peer comps, and catalysts to watch!
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.